Neuroinflammation in Alzheimer's disease continuum

Taskiran-Sag A., Yemisci M.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, vol.37, no.4, pp.155-163, 2020 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Review
  • Volume: 37 Issue: 4
  • Publication Date: 2020
  • Doi Number: 10.4103/nsn.nsn_190_20
  • Journal Name: NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.155-163
  • Hacettepe University Affiliated: Yes

Abstract

Aging population brings an ever-increasing global burden of dementia, and Alzheimer's disease (AD) is the most frequent type worldwide. Many years of research have introduced characteristic cerebral histopathological and molecular changes in this disease. However, all attempts to establish an effective treatment have failed. In this review, we aim to address the basic evidence regarding the role of inflammatory mediators in AD and their link to the other pathogenetic pathways. Novel findings based on advanced biotechnology and bioinformatics are covered briefly, as well.